206 related articles for article (PubMed ID: 3718377)
1. The effect of antimotion sickness drugs on habituation to motion.
Wood CD; Manno JE; Manno BR; Odenheimer RC; Bairnsfather LE
Aviat Space Environ Med; 1986 Jun; 57(6):539-42. PubMed ID: 3718377
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Redetzki HM
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A262-5. PubMed ID: 3675502
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of antimotion sickness drug side effects on performance.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood MJ; Mims ME
Aviat Space Environ Med; 1985 Apr; 56(4):310-6. PubMed ID: 3888169
[TBL] [Abstract][Full Text] [Related]
4. Side effects of antimotion sickness drugs.
Wood CD; Manno JE; Manno BR; Redetzki HM; Wood M; Vekovius WA
Aviat Space Environ Med; 1984 Feb; 55(2):113-6. PubMed ID: 6696702
[TBL] [Abstract][Full Text] [Related]
5. Comparison of efficacy of ginger with various antimotion sickness drugs.
Wood CD; Manno JE; Wood MJ; Manno BR; Mims ME
Clin Res Pr Drug Regul Aff; 1988; 6(2):129-36. PubMed ID: 11538042
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness.
Wood CD; Stewart JJ; Wood MJ; Manno JE; Manno BR; Mims ME
Aviat Space Environ Med; 1990 Feb; 61(2):157-61. PubMed ID: 2178599
[TBL] [Abstract][Full Text] [Related]
7. Human assay of antimotion sickness drugs.
Graybiel A; Wood CD; Knepton J; Hoche JP; Perkins GF
Aviat Space Environ Med; 1975 Sep; 46(9):1107-18. PubMed ID: 1100039
[TBL] [Abstract][Full Text] [Related]
8. Prevention of experimental motion sickness by scopolamine absorbed through the skin.
Graybiel A; Knepton J; Shaw J
Aviat Space Environ Med; 1976 Oct; 47(10):1096-100. PubMed ID: 791234
[TBL] [Abstract][Full Text] [Related]
9. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical.
Clément G; Deguine O; Bourg M; Pavy-LeTraon A
J Vestib Res; 2007; 17(5-6):227-37. PubMed ID: 18626134
[TBL] [Abstract][Full Text] [Related]
10. Habituation and motion sickness.
Wood CD; Stewart JJ; Wood MJ; Struve FA; Straumanis JJ; Mims ME; Patrick GY
J Clin Pharmacol; 1994 Jun; 34(6):628-34. PubMed ID: 8083394
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for motion sickness: cardiovascular effects.
Sunahara FA; Farewell J; Mintz L; Johnson WH
Aviat Space Environ Med; 1987 Sep; 58(9 Pt 2):A270-6. PubMed ID: 3499896
[TBL] [Abstract][Full Text] [Related]
12. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats.
Morita M; Takeda N; Hasegawa S; Yamatodani A; Wada H; Sakai S; Kubo T; Matsunaga T
Acta Otolaryngol; 1990; 110(3-4):196-202. PubMed ID: 2239207
[TBL] [Abstract][Full Text] [Related]
13. Motion sickness in cats: a symptom rating scale used in laboratory and flight tests.
Suri KB; Crampton GH; Daunton NG
Aviat Space Environ Med; 1979 Jun; 50(6):614-8. PubMed ID: 475712
[TBL] [Abstract][Full Text] [Related]
14. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
Collins WE; Schroeder DJ; Elam GW
Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
[TBL] [Abstract][Full Text] [Related]
15. Treatment of motion sickness in parabolic flight with buccal scopolamine.
Norfleet WT; Degioanni JJ; Calkins DS; Reschke MF; Bungo MW; Kutyna FA; Homick JL
Aviat Space Environ Med; 1992 Jan; 63(1):46-51. PubMed ID: 1550533
[TBL] [Abstract][Full Text] [Related]
16. Human centrifuge studies on the relative effectiveness of some antimotion sickness drugs.
Wood CD; Graybiel A; McDonough R
Aerosp Med; 1966 Feb; 37(2):187-90. PubMed ID: 5906041
[No Abstract] [Full Text] [Related]
17. Effect of transdermally administered scopolamine in preventing motion sickness.
McCauley ME; Royal JW; Shaw JE; Schmitt LG
Aviat Space Environ Med; 1979 Nov; 50(11):1108-11. PubMed ID: 393242
[TBL] [Abstract][Full Text] [Related]
18. Effectivity of antimotion sickness drugs during artificial gravity simulations.
Green JA
Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
[No Abstract] [Full Text] [Related]
19. Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.
Graybiel A; Cramer DB; Wood CD
Aviat Space Environ Med; 1982 Aug; 53(8):770-2. PubMed ID: 7181807
[TBL] [Abstract][Full Text] [Related]
20. Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires.
Kennedy RE; Wood CD; Graybiel A; McDonough RB
Aerosp Med; 1966 Apr; 37(4):408-11. PubMed ID: 5954449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
